Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Market perspective Fast-track approval reflects urgency in tackling obesity Oral therapies may capture ~20% of the market by 2030 Expands access for patients preferring pills over injections While Novo Nordisk may offer slightly higher weight loss with its oral option, ease of use and flexibility position this therapy as a strong competitor
Ali Mahmoud Assar M et al
You need to see a doctor any time you see blood in your stool
A healthcare professional may prescribe a different medication if a GLP-1 drug is not available
US$ 29.38
US$ 25.19
US$ 26.11
US$ 22.16
US$ 23.75
